Evidence map›Paper›PMID 34908758›Full record

ArticleAsian journal of transfusion science

Anti-Emm, a rare specificity to the high-incidence antigen Emm in an Indian patient defining the new blood group system EMM (ISBT042).

Ripal J Shah, Snehal B Senjaliya, V Harimoorthy, Anna Burgos, Sunitha Vege, Christine Lomas-Francis, Connie M Westhoff, Sanmukh Ratilal Joshi

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Asian journal of transfusion science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ripal J ShahDirector, Prathama Blood Center, Ahmadabad, Gujarat, India.
Snehal B SenjaliyaResearch Assistant, Lok Samarpan Regional Blood Bank and Research Centre, Surat, Gujarat, India.
V HarimoorthyQuality Section Officer, Prathama Blood Center, Ahmadabad, Gujarat, India.
Anna BurgosLead Technologist, Immunohematology Laboratory, New York, USA.
Sunitha VegeTechnical Director, Genomics Laboratory, New York, USA.
Christine Lomas-FrancisTechnical Director, Immunohematology Laboratory, New York, USA.
Connie M WesthoffExecutive Scientific Director, Immunohematology and Genomics Laboratory, New York Blood Centre, Long Island City, New York, USA.
Sanmukh Ratilal JoshiDirector, Lok Samarpan Regional Blood Bank and Research Centre, Surat, Gujarat, India.
New York Oncology Hematology · USNew York Blood Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A transfusion recipient lacking a high-incidence antigen (HIA) and has corresponding alloantibody pose a problem in providing compatible blood unit. We encountered a patient with an antibody to an HIA that required identification to assess if compatible blood could be organized. A 65-year-old male was posted for coronary artery bypass grafting surgery. His blood specimen collected in EDTA was referred to the blood bank to provide blood for transfusion. The patient, grouped AB RhD+, had an antibody reacting in saline and antiglobulin phases. It agglutinated all the red blood cells (RBCs) of the 11-cell panel and random donors, indicating specificity to an HIA, though one of his siblings was compatible. After ruling out specificity to HIAs such as H, Inb, and INRA (IN5), the specimen was referred to the New York Blood Centre for further work-up. The antibody reacted with examples of red cells lacking HIA, except those with the Emm- phenotype. The patient's RBCs were typed as Emm-. Anti-Emm in the patient appeared to be naturally occurring as there was no history of transfusion. Naturally occurring alloantibody to an HIA, identified as anti-Emm in phenotype Emm-, is rare and the first of its kind to be reported from India. The case was instrumental in recognizing the Emm as the new blood group system assigned with the symbol ISBT042.

Indexed as

EmmEmm− phenotype in Indian subjecthigh-incidence antigennew blood group system

Identifiers

PMID34908758
PMCPMC8628250
OpenAlexW3211307796

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.